Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesCorticosteroids (dexamethasone versus intravenous methylprednisolone) in patients with tuberculous meningitis
Annals of Tropical Medicine and Parasitology, 10/15/09
Malhotra HS et al. – In an open–label study in India, 97 patients with such meningitis were randomized into a control group, a dexamethasone group (with the drug given intravenously once a day for 4 weeks, and then orally, once daily, for another 4 weeks) and a methylprednisolone group (with the drug given intravenously once a day for 5 days). Adverse events were similar and equally reported in the two corticosteroid groups. Larger trials are still needed to determine if dexamethasone and/or methylprednisolone are useful in the treatment of tuberculous meningitis, at least in India.
Related Articles
Dementia and capsular genu ischemia in patients with severe bacterial meningitis
Neurological Sciences, 11/02/09
Relevance Score: 92%
Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature
International Journal of Infectious Diseases, 11/16/09
Relevance Score: 91%
Costs for Households and Community Perception of Meningitis Epidemics in Burkina Faso
Clinical Infectious Diseases, 10/28/09
Relevance Score: 89%
Adhesion molecule levels in serum and cerebrospinal fluid in children with bacterial meningitis and sepsis
Journal of Pediatric Neurosciences, 11/03/09
Relevance Score: 88%
Prevalence and antimicrobial resistance pattern of bacterial meningitis in Egypt
Annals of Clinical Microbiology and Antimicrobials, 10/13/09
Relevance Score: 88%
Today in CNS Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
A Randomized, Multicenter, Open-Label Clinical Trial to Assess the Immunogenicity of a Meningococcal C Vaccine Booster Dose Administered to Children Aged 14 to 18 Months
The Pediatric Infectious Disease Journal, 11/20/09
The prognostic value of amplitude integrated EEG in neonatal sepsis and/or meningitis
Acta Pediatrica, 11/19/09
Magnetic resonance imaging in central nervous system tuberculosis
Indian Journal of Radiology and Imaging, 10/29/09
Article Search
Sponsor